Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
- 1 October 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 7 (10), 854-868
- https://doi.org/10.1038/nrd2681
Abstract
Histone deacetylases (HDACs)--enzymes that affect the acetylation status of histones and other important cellular proteins--have been recognized as potentially useful therapeutic targets for a broad range of human disorders. Pharmacological manipulations using small-molecule HDAC inhibitors--which may restore transcriptional balance to neurons, modulate cytoskeletal function, affect immune responses and enhance protein degradation pathways--have been beneficial in various experimental models of brain diseases. Although mounting data predict a therapeutic benefit for HDAC-based therapy, drug discovery and development of clinical candidates face significant challenges. Here, we summarize the current state of development of HDAC therapeutics and their application for the treatment of human brain disorders such as Rubinstein-Taybi syndrome, Rett syndrome, Friedreich's ataxia, Huntington's disease and multiple sclerosis.Keywords
This publication has 213 references indexed in Scilit:
- SirT1 Inhibition Reduces IGF-I/IRS-2/Ras/ERK1/2 Signaling and Protects NeuronsCell Metabolism, 2008
- HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in ratsBrain Research, 2008
- Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disordersCurrent Opinion in Pharmacology, 2008
- Drug targeting of dysregulated transcription in Huntington's diseaseProgress in Neurobiology, 2007
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007
- SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formationNature, 2007
- Developmental expression of histone deacetylase 11 in the murine brainJournal of Neuroscience Research, 2007
- HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPSNature, 2007
- Chromatin Modifications and Their FunctionCell, 2007
- Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespanNature, 2003